【Abstract】 Background and objective The epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab has been used widely in non-small cell lung cancer patients. The aim of this study is to explore the effect of lung cancer cells (A549, H460, H1299, SPC-A-1) which were treated by cetuximab in vitro. Methods We studied the effects of increasing concentrations of cetuximab (1 nmol/L-625 nmol/L) in four human lung cancer cell lines (A549, SPC-A-1, H460, H1229).
CCK8 measured the inhibition of cell proliferation in each group. A549, SPC-A-1 were marked by PI and the statuses of apoptosis were observed. Western blot were used to detect the proliferation-related signaling protein and apoptosis-related protein in A549. Results The treatment with cetuximab resulted in the effect on cell proliferation and apoptosis in a time-and dosedependent manner. The expression of activated key enzymes (p-AKT, p-EGFR, p-MAPK) in EGFR signaling transduction pathway were down-regulated more obviously. Conclusion Cetuximab is an effective targeted drug in the treatment of lung cancer cell lines, tissues, most likely to contribute to the inhibition of key enzymes in EGFR signaling transduction pathway.
【Key words】 Cetuximab; Lung neoplasms; Cell proliferation; Apoptosis; Epidermal growth factor receptor 
不同浓度西妥昔单抗对A549、SPC-A-1、H460、
H1229细胞株增殖的抑制 在药物作用下，4种细胞株的 增殖均有下降，受到明显的抑制，并随着药物浓度的增 高抑制效果增强（图1）。
H1229细胞株凋亡的影响 药物处理细胞后，多数细胞被 www.lungca.org
